全文获取类型
收费全文 | 11662篇 |
免费 | 604篇 |
国内免费 | 601篇 |
专业分类
12867篇 |
出版年
2024年 | 26篇 |
2023年 | 160篇 |
2022年 | 230篇 |
2021年 | 287篇 |
2020年 | 316篇 |
2019年 | 514篇 |
2018年 | 427篇 |
2017年 | 344篇 |
2016年 | 341篇 |
2015年 | 319篇 |
2014年 | 582篇 |
2013年 | 863篇 |
2012年 | 409篇 |
2011年 | 584篇 |
2010年 | 460篇 |
2009年 | 559篇 |
2008年 | 619篇 |
2007年 | 667篇 |
2006年 | 593篇 |
2005年 | 503篇 |
2004年 | 479篇 |
2003年 | 471篇 |
2002年 | 436篇 |
2001年 | 308篇 |
2000年 | 275篇 |
1999年 | 242篇 |
1998年 | 260篇 |
1997年 | 213篇 |
1996年 | 195篇 |
1995年 | 174篇 |
1994年 | 125篇 |
1993年 | 123篇 |
1992年 | 106篇 |
1991年 | 74篇 |
1990年 | 71篇 |
1989年 | 62篇 |
1988年 | 47篇 |
1987年 | 33篇 |
1986年 | 46篇 |
1985年 | 55篇 |
1984年 | 55篇 |
1983年 | 35篇 |
1982年 | 35篇 |
1981年 | 31篇 |
1980年 | 44篇 |
1979年 | 17篇 |
1978年 | 8篇 |
1977年 | 12篇 |
1974年 | 6篇 |
1973年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
《Journal of receptor and signal transduction research》2013,33(2):139-146
E2F1 promotes DNA damage-induced apoptosis and the post-translational modifications of E2F1 play an important role in the regulation of E2F1-mediated cell death. Here, we found that Set9 and LSD1 regulate E2F1-mediated apoptosis upon DNA damage. Set9 methylates E2F1 at lysine 185, a conserved residue in the DNA-binding domain of E2F family proteins. The methylation of E2F1 by Set9 leads to the stabilization of E2F1 and up-regulation of its proapoptotic target genes p73 and Bim, and thereby induces E2F1-mediated apoptosis in response to genotoxic agents. We also found that LSD1 demethylates E2F1 at lysine 185 and reduces E2F1-mediated cell death. The identification of the methylation/demethylation of E2F1 by Set9/LSD1 suggests that E2F1 is dynamically regulated by epigenetic enzymes in response to DNA damage. 相似文献
992.
《Journal of receptor and signal transduction research》2013,33(4):289-305
AbstractUrotensin‐II (U‐II) was identified as the natural ligand of the G protein‐coupled receptor GPR14, which has been correspondingly renamed Urotensin‐II receptor (U2R). The tissue distribution of U2R and the pharmacological effects of U‐II suggest a novel neurohormonal system with potent cardiovascular effects. We here report the human rhabdomyosarcoma cell line TE‐671 as the first natural and endogenous source of functional U2R in an immortalized cell line. In TE‐671 cells, U‐II stimulated extracellular signal regulated kinase phosphorylation and increased c‐fos mRNA expression. Furthermore, we demonstrate that the expression of U2R mRNA and functional U‐II high affinity binding sites are serum‐responsive and that they are specifically up‐regulated by interferon γ (IFNγ). We propose that IFNγ contributes to the previously observed increase of U2R density in the heart tissue of congestive heart failure (CHF) patients and we suggest that U2R up‐regulation, as a consequence of an inflammatory response, could lead to a clinical worsening of this disease. 相似文献
993.
994.
995.
Laëtitia Coudray Renata Marcia de Figueiredo Stéphanie Duez Sylvie Cortial 《Journal of enzyme inhibition and medicinal chemistry》2013,28(4):972-985
With the aim of creating new bisubstrate inhibitors of protein farnesyltransferase (FTase), new carboxylic farnesyl pyrophosphate analogues have been designed and synthesized. The original structures are built around three elements: a prenyl moiety, a 1,4-diacid motif and an imidazole ring. All the compounds were evaluated for their ability to inhibit FTase and compared with the corresponding derivatives lacking the imidazole ring, synthesized for that purpose. These new compounds are not bisubstrate inhibitors probably because the imidazole ring is not in the right position to interact with the zinc atom. However these derivatives display FPP competitive inhibition with a good activity in the carboxylic farnesyl pyrophosphate analogues series. 相似文献
996.
《Journal of enzyme inhibition and medicinal chemistry》2013,28(3):545-551
Aminopeptidase N (APN/CD13) over expressed on tumour cells, plays a critical role in tumour invasion, metastasis and tumour angiogenesis. In this article, we described the design, synthesis and preliminary activity studies of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as APN inhibitors. The in vitro enzymatic inhibitions on APN from porcine kidney showed that compound 7e had the most potent inhibitory activity against APN with the IC50 value to 1.26?±?0.01 μM, which is better than that of bestatin (IC50?=?2.55?±?0.11 μM). In addition, compound 7e also showed better inhibitory activity against APN on human ovary clear cell carcinoma cell ES-2 than bestatin with the IC50 value to 30.19?±?1.02 μM versus 60.61?±?0.1 μM. Compound 7e could be used as the lead compound in the future for anti-cancer agent research. 相似文献
997.
Ismet Basaran Selma Sinan Umit Cakir Mustafa Bulut Oktay Arslan Ozen Ozensoy 《Journal of enzyme inhibition and medicinal chemistry》2013,28(1):32-36
A new series of 6, 7-dihydroxy-3-(methylphenyl) chromenones, including three new derivatives, i.e. 6,7-dihydroxy-3-(2-methylphenyl)-2H-chromen-2-one (OPC); 6,7-dihydroxy-3-(3-methylphenyl)-2H-chromen-2-one (MPC); 6,7-dihydroxy-3-(4-methylphenyl)-2H-chromen-2-one (PPC) and one previously described, namely 6,7-dihydroxy-3-phenyl-2H-chromen-2-one (DPC), were synthesized. These compounds were investigated as inhibitors of human carbonic anhydrase I (hCA-I) and human carbonic anhydrase II (hCA-II) which had been purified from human erythrocytes on an affinity gel comprised of L-tyrosine-sulfonamide-Sepharose 4B. 相似文献
998.
《Nucleosides, nucleotides & nucleic acids》2013,32(5-8):1567-1570
Abstract Dissociation constants and stoichiometry of binding for interaction of trimeric calf spleen purine nucleoside phosphorylase with potent multisubstrate analogue inhibitors were studied by kinetic and spectrofluorimetric methods. 相似文献
999.
Najim A. Al-Masoudi Ali G. Kassim Nabeel A. Abdul-Reda 《Nucleosides, nucleotides & nucleic acids》2013,32(3):141-161
A series of 4-amino-5-((4-chlorophenyl)diazenyl)-6-(alkylamino)-1-methylpyrimidin-2-one deri- vatives 7–16 were prepared by nucleophilic displacement of 6-chloro-pyrimidine 6 by various amines. 4-Amino-5-((aryl-4-yl)diazenyl)-6-aryl-1-methylpyrimidin-2-one analogs 19–27, as well as 4-amino-5-((aryl-[1,1′-biphenyl]-4-yl)diazenyl)-6-aryl-1-methylpyrimidin-2-one 29–31 and 4-amino-6-aryl-1-methylpyrimidin-2-one 34–34, were synthesized via Suzuki cross-coupling reaction, using Pd(PPh3)4 as a catalyst and arylboronic acids as reagents. All compounds were evaluated for their antiviral activity against the replication of HIV-1 and HIV-2 in MT-4. Compounds 6, 16, 27, and 29 showed a 50% effective concentration of >2.15, >3.03, >2.29, and >1.63 μM, respectively, but no selectivity was observed (selectivity index < 1). Two of the newly synthesized pyrimidines 12 and 29 exhibited moderate kinesin Eg5 inhibition. 相似文献
1000.
Jennifer Sigmond Godefridus J. Peters 《Nucleosides, nucleotides & nucleic acids》2013,32(10-12):1997-2022
In anti-cancer treatment, deoxynucleoside analogues are widely used in combination chemotherapy. Improvement can be achieved by rational design of novel combinations with cell cycle inhibitors. These compounds inhibit protein kinases, preventing the cell cycle from continuing when affected by deoxynucleoside analogs. The efficacy is dependent on the site of cell cycle inhibition, whether multiple cyclin-dependent kinases are inhibited and whether the inhibitors should be given before or after the deoxynucleoside analogs. The action of cell cycle inhibition in vivo may be limited by unfavorable pharmacokinetics. Preclinical and clinical studies will be discussed, aiming to design improved future strategies. 相似文献